Elicio Therapeutics
ELTX----
Elicio Therapeutics (ELTX)
Elicio Therapeutics, Inc., a clinical-stage biotechnology company, develops immunotherapies for the treatment of cancer. Its lead product candidate, ELI-002, is...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
Elicio Therapeutics Analyst Rating
View MoreForecast & Rating
Jul 2, 2026Price forecast
$20.00534.92%
Forecast & RatingBuy
4analysts
- Strong buy75.00%
- Buy0.00%
- Hold25.00%
- Sell0.00%
- Strong sell0.00%
News
- Global Report · Jul 8 at 10:32 PM
Restructuring and Survival Signals: How 10 Off-the-Radar Stocks Are Navigating the Capital Pivot
- benzinga_article · Jul 8 at 12:05 PM
12 Health Care Stocks Moving In Wednesday's Intraday Session
- benzinga_article · Jul 2 at 12:05 PM
11 Health Care Stocks Moving In Thursday's Intraday Session
- benzinga_article · Jul 2 at 07:05 AM
12 Health Care Stocks Moving In Thursday's Pre-Market Session
- rttnews · Jul 1 at 10:22 PM
Top Biotech Gainers: CANF Climbs, RGNT Gears Up For Europe Launch, RNAZ, ELTX On Watch
- StockTitan · Jul 1 at 03:25 PM
Elicio Therapeutics Announces Pricing of $15 Million Registered Direct Offering | ELTX Stock News
